These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1875 related articles for article (PubMed ID: 9153395)

  • 1. Mdm2 promotes the rapid degradation of p53.
    Haupt Y; Maya R; Kazaz A; Oren M
    Nature; 1997 May; 387(6630):296-9. PubMed ID: 9153395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.
    Midgley CA; Desterro JM; Saville MK; Howard S; Sparks A; Hay RT; Lane DP
    Oncogene; 2000 May; 19(19):2312-23. PubMed ID: 10822382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback control.
    Li L; Liao J; Ruland J; Mak TW; Cohen SN
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1619-24. PubMed ID: 11172000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo.
    Böttger A; Böttger V; Sparks A; Liu WL; Howard SF; Lane DP
    Curr Biol; 1997 Nov; 7(11):860-9. PubMed ID: 9382809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Abl neutralizes the inhibitory effect of Mdm2 on p53.
    Sionov RV; Moallem E; Berger M; Kazaz A; Gerlitz O; Ben-Neriah Y; Oren M; Haupt Y
    J Biol Chem; 1999 Mar; 274(13):8371-4. PubMed ID: 10085066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 protein stability in tumour cells is not determined by mutation but is dependent on Mdm2 binding.
    Midgley CA; Lane DP
    Oncogene; 1997 Sep; 15(10):1179-89. PubMed ID: 9294611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth.
    Swaroop M; Sun Y
    Anticancer Res; 2003; 23(4):3167-74. PubMed ID: 12926050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop.
    Arriola EL; Lopez AR; Chresta CM
    Oncogene; 1999 Jan; 18(4):1081-91. PubMed ID: 10023685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleolar Arf sequesters Mdm2 and activates p53.
    Weber JD; Taylor LJ; Roussel MF; Sherr CJ; Bar-Sagi D
    Nat Cell Biol; 1999 May; 1(1):20-6. PubMed ID: 10559859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
    Honda R; Yasuda H
    EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of p53 stability by Mdm2.
    Kubbutat MH; Jones SN; Vousden KH
    Nature; 1997 May; 387(6630):299-303. PubMed ID: 9153396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products.
    Yin Y; Stephen CW; Luciani MG; Fåhraeus R
    Nat Cell Biol; 2002 Jun; 4(6):462-7. PubMed ID: 12032546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDM2 and MDMX bind and stabilize the p53-related protein p73.
    Ongkeko WM; Wang XQ; Siu WY; Lau AW; Yamashita K; Harris AL; Cox LS; Poon RY
    Curr Biol; 1999 Jul 29-Aug 12; 9(15):829-32. PubMed ID: 10469568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulation of the mdm2 oncogene by p53 requires TRRAP acetyltransferase complexes.
    Ard PG; Chatterjee C; Kunjibettu S; Adside LR; Gralinski LE; McMahon SB
    Mol Cell Biol; 2002 Aug; 22(16):5650-61. PubMed ID: 12138177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of Mdm2 and enhancement of cell survival by bFGF.
    Shaulian E; Resnitzky D; Shifman O; Blandino G; Amsterdam A; Yayon A; Oren M
    Oncogene; 1997 Nov; 15(22):2717-25. PubMed ID: 9400998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MdmX protects p53 from Mdm2-mediated degradation.
    Jackson MW; Berberich SJ
    Mol Cell Biol; 2000 Feb; 20(3):1001-7. PubMed ID: 10629057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hdmx and Mdm2 can repress transcription activation by p53 but not by p63.
    Little NA; Jochemsen AG
    Oncogene; 2001 Jul; 20(33):4576-80. PubMed ID: 11494153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between the retinoblastoma protein and the oncoprotein MDM2.
    Xiao ZX; Chen J; Levine AJ; Modjtahedi N; Xing J; Sellers WR; Livingston DM
    Nature; 1995 Jun; 375(6533):694-8. PubMed ID: 7791904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2.
    Unger T; Juven-Gershon T; Moallem E; Berger M; Vogt Sionov R; Lozano G; Oren M; Haupt Y
    EMBO J; 1999 Apr; 18(7):1805-14. PubMed ID: 10202144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2.
    Li M; Brooks CL; Wu-Baer F; Chen D; Baer R; Gu W
    Science; 2003 Dec; 302(5652):1972-5. PubMed ID: 14671306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 94.